TrialCephalalgia : an international journal of headache2019

Safety and tolerability of ubrogepant following intermittent, high-frequency dosing: Randomized, placebo-controlled trial in healthy adults.

Peter J Goadsby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.